Heard On The Street: Dealers Spot Action In PNB Housing, Axis Bank, Dr. Reddy’s, Kotak Mahindra Bank And More
NDTV Profit India has been tracking the action in the top dealing rooms of India's financial capital, and this edition of ‘Heard On The Street' provides you with buzzing action on stocks like PNB Housing, Axis Bank, Dr Reddy's, Divis Lab, Kotak Mahindra Bank and JSPL.
Heard On The Street provides readers with what well-informed investors, especially HNIs, FIIs, DIIs, and mutual funds, are buying and selling in the stock market. It also tracks the latest unconfirmed/unverified chatter around stocks and/or sectors.
NDTV Profit picked up the following cues from the dealing room chatter during trade:
PNB Housing
Dealers indicate that Carlyle Group has appointed bankers to sell its stake in PNB Housing. Carlyle holds a 10.4% stake under the name of Quality Investment in the NBFC. It can be a clean-out trade as well.
Axis Bank
Recently the bank, in its board meeting, approved a fundraise of Rs 20,000 crore via equity. Dealers indicate that the bank will be launching its qualified institutional placement anytime soon.
Dr Reddy and Divis Lab
Dealers indicate that large HNIs have been taking the following positional trade – sell Dr Reddy's and buy Divis Lab.
Kotak Mahindra Bank
The share prices of Kotak Mahindra Bank stood out in the Nifty Bank index, given that it was trading higher despite the weakness in the Nifty Bank index. However, dealers indicate there are sell flows on the domestic institutional desk at higher levels in Kotak Mahindra Bank.
JSPL
Large high-net-worth individuals have been accumulating ahead of the Q4 earnings in anticipation of a positive announcement related to mine opening.
Disclaimer: The mentioned stocks capture NDTV Profit's dealing room channel checks during trading hours. The information provided is for informational purposes. However, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, or suitability of the information. This content does not constitute financial, investment, or trading advice and should not be construed as a recommendation to buy, sell, or hold any securities.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
